Update publication information Lung cancer in Chinese patients has distinct genomic features and lung squamous cell carcinoma (LUSC) has limited biomarkers for targeted therapy even though a lot of progress has been made in genomics research. Systematical research on LUSC at protein level will be beneficial to improve precision medicine. In this study, the large scale proteomics and phosphoproteomics analysis on clinical Chinese LUSC patients were performed.